Company Financials
BioVie Inc. Financials
United States dollar
business
BioVie Inc. Company Profile
Main Stock Listing
NASDAQ: BIVI
Market Capitalization $17.8 Million as of July 1, 2025
Market Cap History
Valuations Metrics as of May. 5, 2024
| Trailing PE | -0.32 |
| Forward PE | -0.38 |
| Price to Sales TTM | $ |
| Price to Book MRQ | $2.61 |
| Enterprise to Revenue | |
| Enterprise to EBITDA | -0.22 |
Financial Reports as of Dec. 31, 2023
Financials
| Fiscal Year Ends | 2023-06-30 |
| Most Recent Quarter | 2023-12-31 |
| Profit Margin | 0.00% |
| Operating Margin | 0.00% |
| Return on Assets TTM | -80.82% |
| Return on Equity TTM | -257.84% |
Income Statement
| Revenue TTM | $0 |
| Revenue per Share TTM | $0.00 |
| Quarterly Revenue Growth | % |
| Gross Profit TTM | $0 |
| EBITDA | $-44,179,156 |
| Net Income to Common TTM | $-43,265,012 |
| Diluted EPS TTM | $-1.17 |
| Quarterly Earnings Growth YoY | % |
Balance Sheet
| Total Cash MRQ | $20,226,698 |
| Total Cash per Share MRQ | $0.51 |
| Total Debt MRQ | $ |
| Total Debt to Equity MRQ | 136.98 |
| Current Ratio MRQ | 1.47 |
| Book Value per Share MRQ | $0.19 |
Cash Flow
| Operating Cash Flow TTM | $-41,110,232 |
| Levered Free Cash Flow TTM | $-29,669,398 |
BIVI Stock Info as of May. 5, 2024
Stock Statistics
| Shares Outstanding | 54,924,600 |
| Float Shares | 22,505,078 |
| Avg 10 Volume | 594,971 |
| Avg 30 Volume | None |
| Shares Short | 1,113,059 |
| Short Ratio | 1.07 |
| Short % of Shares | 3.55% |
| % Held by Insiders | 43.25% |
| % Held by Institutions | 4.48% |
Stock Price Summary
| Beta | 1.21 |
| Fifty Two Week Low | $0.45 |
| Fifty Two Week High | $8.69 |
| Fifty Two Week Change | -1590.46% |
| Day 50 MA | $0.68 |
| Day 200 MA | $2.29 |
Dividends and Splits
| Forward Annual Dividend Rate | $ |
| Forward Annual Dividend Yield | % |
| Trailing Annual Dividend Rate | $0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Dividend Date | 2019-11-22 |
| Ex Dividend Date | |
| Last Split Factor | |
| Last Split Date |